SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-003323
Filing Date
2017-04-04
Accepted
2017-04-04 16:16:13
Documents
1
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4033117krumeich_soligenix.html 4  
1 OWNERSHIP DOCUMENT f4033117krumeich_soligenix.xml 4 3999
  Complete submission text file 0001213900-17-003323.txt   5662
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 WEST MAIN STREET SUITE 201 IRVINGTON NY 10533
Business Address
Krumeich Karen R (Reporting) CIK: 0001334797 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14778 | Film No.: 17738374